Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to:

Compare the effect of paracetamol alone against NSAIDs alone against the association of paracetamol + NSAIDs in the treatment of traumatic pain.


Clinical Trial Description

Paracetamol, NSAIDs, or a combination of the two molecules are usually prescribed. Patients even use these medications without a prescription. It is not known, however, whether or not NSAIDs have an additional value relative to paracetamol for the treatment of pain.

All patients were assigned in a 1:1:1 ratio. Randomization of subjects was performed centrally according to a computer-generated random code provided by one of investigators who was not involved in any other part of the trial. The patients included were divided into 3 groups: Paracetamol group who received paracetamol 1000 mg orally every 8th hour for 7 days; NSAID group who received piroxicam 20 mg orally twice a day for 7 days, and Paracetamol-NSAID combination who received both treatments at the same doses for 7 days. All protocol treatments were administered in opaque packets with code number according to the randomization list by an independent nurse who was not involved in monitoring or follow-up of the individuals. Data were collected for each patient, including demographics, medical history, and findings of the clinical examination. Injury Severity Score (ISS) whose values range from 0 to 75 was also assessed. Each patient was re-evaluated on the 3rd and 7th day post-trauma (D7) using a telephone contact by a clinical research associates who was blinded to the details of the study to note the following clinical data: pain VNS, ED readmissions for residual pain, need for other analgesics other than those of the protocol, other treatment modalities the patient might have used (adherence to the treatment prescribed), and side effects. In addition patients were asked about their satisfaction with pain control following ED using five point Likert scale: very dissatisfied, not satisfied, neutral, satisfied and very satisfied and about the degree to which they adhered to medication schedule. The principal investigator who was aware of the allocation was not involved in monitoring or recording of the outcomes until the data collection was completed. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03222518
Study type Interventional
Source University of Monastir
Contact
Status Completed
Phase Phase 3
Start date March 1, 2017
Completion date November 1, 2018

See also
  Status Clinical Trial Phase
Completed NCT03247179 - The Mobile PTSD Coach App in Acute Injury Survivors N/A
Completed NCT04133623 - Ibuprofen Versus Ketorolac by Mouth in the Treatment of Acute Pain From Osteoarticular Trauma Phase 3
Completed NCT05229965 - Paracetamol Vs Caffeine Vs Codeine in the Management of Post Traumatic Pain in Emergencies Phase 3
Completed NCT05630222 - Evaluation of Effect of Intravenous Morphine vs Intravenous Ibuprofen and Acetaminophen vs Intravenous Ibuprofen Phase 3
Recruiting NCT06351137 - Timecost of Intranasal Versus Intravenous Analgesia in Traumatic Pain N/A
Completed NCT03256903 - Methoxyflurane vs Standard Analgesic Treatment for Trauma Pain in Spanish Emergency Units Phase 3
Completed NCT03080350 - Sublingual Versus Endovenous Fentanyl for the Prehospital Analgesia in Patients With Limb Trauma on the Slope Phase 4
Recruiting NCT06051227 - Fentanyl OR Esketamine for Traumatic PAIN (FORE-PAIN) Trial Phase 3
Completed NCT04914988 - Continuous Fascia Iliaca Compartment Block in Geriatric Hip Fracture
Recruiting NCT03421275 - Intranasal Esketamine and Fentanyl for Pain in Minor Trauma Phase 4
Completed NCT03080324 - Sublingual Versus Endovenous Fentanyl for Pain Treatment in Trauma Patients in the Emergency Room Phase 4
Completed NCT01420159 - Efficacy and Safety of Methoxyflurane (Penthrox) for the Treatment of Acute Pain in Minor Trauma Phase 3
Completed NCT03597945 - Magnesium-sulfate as Adjuvant in Prehospital Femoral Nerve Block for Patient With Diaphysial Femoral Fracture. N/A